BlackRock Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$254M Buy
4,053,124
+178,702
+5% +$10.9M 0.29% 68
2016
Q3
$244M Sell
3,874,422
-56,261
-1% -$3.64M 0.3% 61
2016
Q2
$243M Sell
3,930,683
-974,797
-20% -$59.4M 0.31% 65
2016
Q1
$280M Sell
4,905,480
-1,501,611
-23% -$83.7M 0.36% 51
2015
Q4
$380M Sell
6,407,091
-1,148,173
-15% -$66.1M 0.49% 37
2015
Q3
$411M Sell
7,555,264
-1,996,880
-21% -$130M 0.56% 28
2015
Q2
$642M Buy
9,552,144
+1,694,770
+22% +$111M 0.8% 15
2015
Q1
$460M Sell
7,857,374
-623,295
-7% -$37.7M 0.6% 28
2014
Q4
$555M Sell
8,480,669
-327,314
-4% -$20.6M 0.74% 19
2014
Q3
$509M Buy
8,807,983
+123,227
+1% +$6.84M 0.71% 20
2014
Q2
$490M Buy
8,684,756
+1,640,119
+23% +$86M 0.66% 20
2014
Q1
$362M Buy
7,044,637
+441,308
+7% +$22.3M 0.53% 33
2013
Q4
$349M Buy
6,603,329
+576,600
+10% +$28.3M 0.52% 34
2013
Q3
$270M Buy
6,026,729
+709,585
+13% +$31.5M 0.44% 40
2013
Q2
$220M Buy
+5,317,144
New +$233M 0.39% 49

Other funds holding ABBV

BlackRock Investment Management's ABBV Position: Q4 2016 in Review

BlackRock Investment Management increased its AbbVie (ABBV) stake by 4.6% in Q4 2016, buying an estimated $10.9M and bringing the position to 4,053,124 shares worth $254M. The position accounts for 0.29% of the portfolio, ranked #68.

BlackRock Investment Management first reported a position in ABBV in Q2 2013 and has held it in 15 quarters since. The position peaked at $642M in Q2 2015. 1,691 funds tracked by Wall St. Rank hold ABBV as of Q4 2016.

  • BlackRock Investment Management held 4,053,124 shares of AbbVie worth $254M as of Q4 2016.
  • BlackRock Investment Management bought 178,702 AbbVie shares in Q4 2016, an estimated $10.9M.
  • AbbVie made up 0.29% of BlackRock Investment Management's portfolio in Q4 2016, its #68 holding.
  • BlackRock Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's AbbVie position peaked at $642M in Q2 2015.
  • 1,691 funds tracked by Wall St. Rank held AbbVie as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.